Gut Microbiota and Metabolome Changes in Three Pulmonary Hypertension Rat Models
Microorganisms · 13.02.2023 · 11 (2) · 472
DOI: 10.3390/microorganisms11020472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 13.02.2023. Verfasst von Lingjie Luo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Microbial Genetic Engineering, Vascular Disease Research Center, College of Life Sciences and Oceanography, Shenzhen Unive…. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen Municipal Basic Research Program Grant.
Abstract (Originalsprache)
Dysbiosis of the gut microbiota and metabolites is found in both pulmonary hypertension patients and pulmonary hypertension rodent models. However, the exact changes in gut microbiota during the development of pulmonary hypertension is unclear. The function of the gut microbiota is also ambiguous. Here, this study showed that the gut microbiota was disrupted in rats with hypoxia (Hyp)-, hypoxia/Sugen5416 (HySu)-, and monocrotaline (MCT)-induced pulmonary hypertension. The gut microbiota is dynamically changed during the development of Hyp-, HySu-, and MCT-induced rat pulmonary hypertension. The variation in the α diversity of the gut microbiota in Hyp-induced pulmonary hypertension rats was similar to that in rats with MCT-induced pulmonary hypertension and different from that in rats with HySu-induced pulmonary hypertension. In addition, six plasma biomarkers, His, Ala, Ser, ADMA, 2-hydroxybutyric acid, and cystathionine, were identified in Hyp-induced pulmonary hypertension rats. Furthermore, a disease-associated network connecting Streptococcus with Hyp-induced pulmonary hypertension-associated metabolites was described here, including trimethylamine N-oxide, Asp, Asn, Lys, His, Ser, Pro, and Ile.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shenzhen Key Laboratory of Microbial Genetic Engineering, Vascular Disease Research Center, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China.
- School of Pharmaceutical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen 518060, China.
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Key Laboratory of Regional Immunity and Diseases
- Shenzhen Municipal Basic Research Program Grant
- Shenzhen-Hong Kong Collaborative Innovation Research
Zitieren
APA
Luo, L., Yin, H., & Gou, D. (2023). Gut Microbiota and Metabolome Changes in Three Pulmonary Hypertension Rat Models. Microorganisms, 11(2), 472. https://doi.org/10.3390/microorganisms11020472
Vancouver
Luo L, Yin H, Gou D. Gut Microbiota and Metabolome Changes in Three Pulmonary Hypertension Rat Models. Microorganisms. 2023;11(2):472. doi:10.3390/microorganisms11020472
BibTeX
@article{Luo2023,
author = {Luo, Lingjie and Yin, Haoyang and Gou, Deming},
title = {Gut Microbiota and Metabolome Changes in Three Pulmonary Hypertension Rat Models},
journal = {Microorganisms},
year = {2023},
volume = {11},
number = {2},
pages = {472},
doi = {10.3390/microorganisms11020472}
}
EUVIMED